Cardiovascular Diseases:
Heart Attack and Heart Failure

Chest pain and shortness of breath are leading reasons for visits to U.S. emergency departments. Information from the National Hospital Ambulatory Medical Care Survey suggests that in 2006 there were more than 6 million emergency department visits made by adults suffering from chest pain and more than 3 million visits related to breathing difficulty. Additionally, the American Heart Association reports that in 2006, nearly 5.7 million individuals in the United States suffered from heart failure, with 670,000 new cases diagnosed. For these patients, time is a significant factor. Early detection of heart failure or heart attack significantly improves a patient's chances for living and minimizes the chances for permanent damage to tissue and organs.

Click on the product names for more information relating to:

Triage^® Cardiac Panel

A rapid, objective aid in the diagnosis of heart attack, the Triage Cardiac Panel measures three key cardiac markers: myoglobin, CK-MB, and troponin I. The system is easy-to-use, with results delivered in approximately 15 minutes.

Triage^® BNP Test

Used in more than 3,000 hospitals and physician offices, the Triage BNP Test aids in the diagnosis and severity assessment of heart failure. The product is also cleared for use in the risk stratification of patients with acute coronary syndromes.

Triage^® Cardio ProfilER^® Panel

With the Triage Cardio ProfilER Panel, physicians can easily obtain the measurements of four cardiovascular markers in approximately 15 minutes, without sacrificing accuracy. This rapid turnaround time enables physicians to more efficiently diagnose chest pain patients, provides a better understanding of the event, and reduces the time-to-diagnose. Troponin I, CK-MB, myoglobin, and BNP each provide unique clinical information, and the panel approach maximizes the strengths of each marker.

Triage^® Profiler Shortness of Breath Panel

With the Triage Profiler Shortness of Breath Panel, physicians can easily obtain the measurements of five markers in approximately 15 minutes, without sacrificing accuracy. This rapid turnaround time enables physicians to more efficiently diagnose patients who present with shortness of breath, provides a better understanding of the event, and reduces the time-to-diagnose. Troponin I, CK-MB, myoglobin, BNP and D-dimer each provide unique clinical information, and the panel approach maximizes the strengths of each marker.

NEW! Triage^® NGAL Test(Not available in the USA)

Biosite proudly announces the availability of the Triage^® NGAL Test for the rapid quantitative determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL). With the simple application of ~250 µl of EDTA anticoagulated whole blood or plasma, it provides a quantitative result in approximately 15 minutes at either the point of care or in the clinical lab. This test requires no sample processing, precision pipetting or daily liquid controls and runs on the established Triage^® Meters, which are widely deployed throughout the world.